Hanna P. Lesch

1.7k total citations
35 papers, 1.3k citations indexed

About

Hanna P. Lesch is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Hanna P. Lesch has authored 35 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 26 papers in Genetics and 9 papers in Oncology. Recurrent topics in Hanna P. Lesch's work include Virus-based gene therapy research (24 papers), Viral Infectious Diseases and Gene Expression in Insects (15 papers) and CAR-T cell therapy research (7 papers). Hanna P. Lesch is often cited by papers focused on Virus-based gene therapy research (24 papers), Viral Infectious Diseases and Gene Expression in Insects (15 papers) and CAR-T cell therapy research (7 papers). Hanna P. Lesch collaborates with scholars based in Finland, United States and France. Hanna P. Lesch's co-authors include Seppo Ylä‐Herttuala, Minna U. Kaikkonen, Jere T. Pikkarainen, David Gosselin, Michael T. Lam, Han Cho, Ronald M. Evans, Christopher K. Glass, Kari J. Airenne and Michael G. Rosenfeld and has published in prestigious journals such as Nature, Circulation Research and Cancer Research.

In The Last Decade

Hanna P. Lesch

35 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hanna P. Lesch Finland 18 940 398 157 148 113 35 1.3k
Yoichi Miyamoto Japan 25 1.6k 1.7× 235 0.6× 106 0.7× 174 1.2× 138 1.2× 62 2.3k
Khursheed Anwer United States 27 1.2k 1.3× 482 1.2× 67 0.4× 171 1.2× 357 3.2× 53 1.9k
Elizabeth M. Hadac United States 29 1.8k 1.9× 503 1.3× 74 0.5× 487 3.3× 152 1.3× 57 2.5k
Antonio L. Amelio United States 20 985 1.0× 195 0.5× 522 3.3× 259 1.8× 173 1.5× 45 1.7k
Klaas W. Mulder Netherlands 20 1.7k 1.9× 158 0.4× 153 1.0× 252 1.7× 150 1.3× 34 2.3k
A J Brake United States 11 1.3k 1.4× 209 0.5× 74 0.5× 215 1.5× 156 1.4× 13 2.1k
Queta Boese United States 7 2.0k 2.1× 299 0.8× 468 3.0× 78 0.5× 145 1.3× 8 2.3k
Scott D. Rose United States 21 1.4k 1.4× 365 0.9× 287 1.8× 101 0.7× 100 0.9× 34 1.8k
Chiao-Chain Huang United States 10 1.3k 1.4× 328 0.8× 76 0.5× 141 1.0× 200 1.8× 15 1.7k
Donald D. Rao United States 15 803 0.9× 156 0.4× 243 1.5× 118 0.8× 70 0.6× 22 1.1k

Countries citing papers authored by Hanna P. Lesch

Since Specialization
Citations

This map shows the geographic impact of Hanna P. Lesch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanna P. Lesch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanna P. Lesch more than expected).

Fields of papers citing papers by Hanna P. Lesch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanna P. Lesch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanna P. Lesch. The network helps show where Hanna P. Lesch may publish in the future.

Co-authorship network of co-authors of Hanna P. Lesch

This figure shows the co-authorship network connecting the top 25 collaborators of Hanna P. Lesch. A scholar is included among the top collaborators of Hanna P. Lesch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanna P. Lesch. Hanna P. Lesch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spadiut, Oliver, et al.. (2025). CGT 4.0: a distant dream or inevitable future? Smart process automation is critical to make efficient scalability of CGT manufacturing a reality. Frontiers in Bioengineering and Biotechnology. 13. 1563878–1563878. 2 indexed citations
2.
3.
Galibert, Lionel, et al.. (2021). Functional roles of the membrane-associated AAV protein MAAP. Scientific Reports. 11(1). 21698–21698. 39 indexed citations
4.
Bowen, Sean, Hanna Leinonen, Hanna P. Lesch, et al.. (2020). Detection of lentiviral suicide gene therapy in C6 rat glioma using hyperpolarised [1‐13C]pyruvate. NMR in Biomedicine. 33(4). e4250–e4250. 5 indexed citations
5.
Oruetxebarria, Igor, Hanna Leinonen, Tommi Heikura, et al.. (2020). Development of Large-Scale Downstream Processing for Lentiviral Vectors. Molecular Therapy — Methods & Clinical Development. 17. 717–730. 49 indexed citations
6.
Leinonen, Hanna, et al.. (2020). Benchmarking of Scale-X Bioreactor System in Lentiviral and Adenoviral Vector Production. Human Gene Therapy. 31(5-6). 376–384. 19 indexed citations
7.
Leinonen, Hanna, et al.. (2017). Optimization of lentiviral vector production for scale-up in fixed-bed bioreactor. Gene Therapy. 25(1). 39–46. 62 indexed citations
8.
Eichenfield, Dawn Z., Ty D. Troutman, Verena M. Link, et al.. (2016). Tissue damage drives co-localization of NF-κB, Smad3, and Nrf2 to direct Rev-erb sensitive wound repair in mouse macrophages. eLife. 5. 56 indexed citations
9.
Lesch, Hanna P., et al.. (2015). Process Development of Adenoviral Vector Production in Fixed Bed Bioreactor: From Bench to Commercial Scale. Human Gene Therapy. 26(8). 560–571. 34 indexed citations
10.
Timonen, Oskari, et al.. (2014). Lentiviral Protein Transduction with Genome-Modifying HIV-1 Integrase-I-PpoI Fusion Proteins: Studies on Specificity and Cytotoxicity. BioMed Research International. 2014. 1–11. 8 indexed citations
11.
Huhtala, Tuulia, et al.. (2013). Biodistribution and antitumor effect of Cetuximab-targeted lentivirus. Nuclear Medicine and Biology. 41(1). 77–83. 4 indexed citations
12.
Leinonen, Hanna, Anna‐Kaisa Ruotsalainen, Ann‐Marie Määttä, et al.. (2012). Oxidative Stress-Regulated Lentiviral TK/GCV Gene Therapy for Lung Cancer Treatment. Cancer Research. 72(23). 6227–6235. 37 indexed citations
13.
Kaikkonen, Minna U., Marjo Jauhiainen, David L. Selwood, et al.. (2012). Targeted delivery via avidin fusion protein: Intracellular fate of biotinylated doxorubicin derivative and cellular uptake kinetics and biodistribution of biotinylated liposomes. European Journal of Pharmaceutical Sciences. 47(5). 848–856. 17 indexed citations
14.
Lesch, Hanna P., Cristina Peixoto, Tiago Vicente, et al.. (2011). Production and purification of lentiviral vectors generated in 293T suspension cells with baculoviral vectors. Gene Therapy. 18(6). 531–538. 48 indexed citations
15.
Lesch, Hanna P., et al.. (2011). Requirements for baculoviruses for clinical gene therapy applications. Journal of Invertebrate Pathology. 107. S106–S112. 16 indexed citations
16.
Lesch, Hanna P., Minna U. Kaikkonen, Jere T. Pikkarainen, & Seppo Ylä‐Herttuala. (2010). Avidin-biotin technology in targeted therapy. Expert Opinion on Drug Delivery. 7(5). 551–564. 165 indexed citations
17.
Kaikkonen, Minna U., Hanna P. Lesch, Jere T. Pikkarainen, et al.. (2009). (Strept)avidin-displaying lentiviruses as versatile tools for targeting and dual imaging of gene delivery. Gene Therapy. 16(7). 894–904. 20 indexed citations
18.
Lesch, Hanna P., Antti Määttä, Pyry I. Toivanen, et al.. (2009). A 96-well format for a high-throughput baculovirus generation, fast titering and recombinant protein production in insect and mammalian cells. BMC Research Notes. 2(1). 63–63. 23 indexed citations
19.
Lesch, Hanna P., et al.. (2008). Generation of lentivirus vectors using recombinant baculoviruses. Gene Therapy. 15(18). 1280–1286. 36 indexed citations
20.
Mähönen, Anssi J., et al.. (2004). Optimized self-excising Cre-expression cassette for mammalian cells. Biochemical and Biophysical Research Communications. 320(2). 366–371. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoichi Miyamoto Breakdown of academic impact, for papers by Khursheed Anwer Breakdown of academic impact, for papers by Elizabeth M. Hadac Breakdown of academic impact, for papers by Antonio L. Amelio Breakdown of academic impact, for papers by Klaas W. Mulder Breakdown of academic impact, for papers by A J Brake Breakdown of academic impact, for papers by Queta Boese Breakdown of academic impact, for papers by Scott D. Rose Breakdown of academic impact, for papers by Chiao-Chain Huang Breakdown of academic impact, for papers by Donald D. Rao
Rankless by CCL
2026